Shanghai MicroPort Endovascular MedTech Co., Ltd. (SHA:688016)
China flag China · Delayed Price · Currency is CNY
86.34
+1.04 (1.22%)
Nov 13, 2026, 3:00 PM CST

SHA:688016 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
1,4551,3501,2031,187896.5684.63
Other Revenue
0.140.143.670.01--
1,4551,3511,2061,187896.5684.63
Revenue Growth
16.24%11.96%1.61%32.43%30.95%45.59%
Cost of Revenue
391.37399.84330.27285.93224.74154
Gross Profit
1,063950.79876.06901.27671.76530.63
Selling, General & Admin
296.43290.25250.25185.19150.02103.81
Research & Development
105.8767.7993.77172.88137.54102.27
Other Operating Expenses
29.95-0.246.587.58.35.32
Operating Expenses
437.81366.1353.85366.91298.49212.68
Operating Income
625.6584.69522.21534.36373.27317.95
Interest Expense
-1.52-2.16-1.65-1.82-2.09-1.77
Interest & Investment Income
19.4126.9104.518.4115.3628.79
Currency Exchange Gain (Loss)
-4.47-4.471.591.192-0.44
Other Non Operating Income (Expenses)
-13.48-0.16-0.38-0.22-0.24-0.16
EBT Excluding Unusual Items
625.55604.8626.26551.92388.29344.38
Gain (Loss) on Sale of Investments
0.370.37----
Gain (Loss) on Sale of Assets
-0.06-0.09-0.7-0.1-0.23-
Asset Writedown
-1.2-----
Other Unusual Items
48.5648.426.6320.4425.8317.28
Pretax Income
673.21653.49652.19572.27413.9361.66
Income Tax Expense
104.2798.83159.4585.0561.8448.15
Earnings From Continuing Operations
568.95554.66492.75487.22352.05313.51
Minority Interest in Earnings
13.898.679.355.214.832.34
Net Income
582.84563.33502.1492.43356.88315.86
Net Income to Common
582.84563.33502.1492.43356.88315.86
Net Income Growth
54.26%12.19%1.96%37.98%12.99%47.17%
Shares Outstanding (Basic)
121121123108107107
Shares Outstanding (Diluted)
121121123108107107
Shares Change
-0.75%-1.80%14.50%0.50%0.00%-0.10%
EPS (Basic)
4.824.654.074.573.332.95
EPS (Diluted)
4.824.654.074.573.332.95
EPS Growth
55.43%14.25%-10.95%37.30%12.99%47.32%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
232.21270.03160.95368.0539.78210.67
Free Cash Flow Per Share
1.922.231.303.420.371.97
Dividend Per Share
1.0002.3002.0122.0131.5441.409
Dividend Growth
-39.83%14.31%-0.07%30.44%9.52%133.34%
Gross Margin
73.10%70.40%72.62%75.91%74.93%77.51%
Operating Margin
43.00%43.29%43.29%45.01%41.64%46.44%
Profit Margin
40.06%41.71%41.62%41.48%39.81%46.13%
Free Cash Flow Margin
15.96%19.99%13.34%31.00%4.44%30.77%
EBITDA
707.94648.06560.3558.39395.92333.41
EBITDA Margin
48.66%47.98%46.45%47.03%44.16%48.70%
D&A For EBITDA
82.3463.3838.124.0322.6515.46
EBIT
625.6584.69522.21534.36373.27317.95
EBIT Margin
43.00%43.29%43.29%45.01%41.64%46.44%
Effective Tax Rate
15.49%15.12%24.45%14.86%14.94%13.31%
Revenue as Reported
1,4551,3511,2061,187896.5684.63